Strive to cultivate 35 listed enterprises and 2-3 demonstration enterprises with a market value of more than 100 billion yuan by 2025… On January 26, the implementation plan for promoting the high-quality development of medical device industry in Guangdong Province was released to formulate a “road map” for the development of medical device industry in Guangdong.
The plan proposes that by 2025, the annual revenue of medical device manufacturing industry above Designated Size in Guangdong will reach 250 billion yuan; 50 national Innovation Medical Management Co.Ltd(002173) device registration certificates have been approved; Cultivate 35 listed enterprises, 2-3 demonstration enterprises with a market value of more than 100 billion yuan, 3-5 leading enterprises with an annual revenue of more than 10 billion yuan and 5-8 leading enterprises with an annual revenue of more than 5 billion yuan; Build a number of backbone enterprises with independent brands with international influence and form a world-class high-end medical device industry cluster.
In terms of expanding direct financing channels, the plan proposes to continuously promote high-quality enterprises to be listed and financed in domestic and foreign securities markets, and support qualified enterprises to expand direct financing channels through equity financing, corporate credit bonds, asset securitization and other means. Guide all kinds of equity investment institutions, private equity investment funds and venture capital funds to invest in the medical device industry. Improve the investment of government guided funds in the seed stage and angel stage of enterprises, and encourage teams or industrial companies with medical industry background to initiate the establishment of venture capital funds, angel funds and other early-stage medical industry sub funds. Listed companies, companies listed on the new third board and companies to be listed that have completed counseling and filing will be included in the scope of priority review and approval services.
Guangdong will implement echelon cultivation of medical device enterprises. Leading enterprises are encouraged to focus on the key links and core technologies of the industrial chain, carry out joint ventures, mergers and acquisitions, integrate resources and complement each other’s advantages. We will guide small and medium-sized medical device enterprises to focus on key core technologies, improve their innovation ability and market share, and take the development path of “specialization and innovation”. Cultivate a number of “little giant” enterprises in the subdivided field of medical devices and single champion enterprises in manufacturing industry. Enhance the leading role of leading and backbone enterprises, strengthen professional cooperation and supporting capacity, and further promote the development of industrial clusters. Vigorously promote the construction of national advanced manufacturing clusters of “Shenzhen Guangzhou high-end medical devices”, and promote the agglomeration of advantageous resource elements and cross industry coordination.
Accelerate the clinical promotion and use of Innovation Medical Management Co.Ltd(002173) devices. The plan proposes to improve medical service prices and medical insurance payment policies, dynamically adjust the catalogue of medical consumables and medical service prices, timely include new products of medical consumables into the scope of medical insurance payment according to regulations, improve the coordination mechanism between medical insurance payment standards and centralized purchase prices, and actively promote the direct settlement between medical insurance funds and medical consumables enterprises. Medical institutions are encouraged to increase the procurement and use of domestic medical devices with accurate efficacy, controllable quality and stable supply.
